ALLK Allakos Therapeutics Total Asset Value of Company
This daily price chart for Allakos Inc. (ALLK) total assets stands at 118.42. Allakos Inc. develops antibodies for rare eosinophilic pathologies, leveraging the success of the AK006 drug and its patent portfolio, which increases the likelihood of acquisition by industry behemoths. However, uncertainty regarding test outcomes poses a risk of a price collapse. Meanwhile, R&D centers are operating steadily, and cleanroom equipment is maintained in pristine condition.
Analytical breakdowns and data insights for company allakos.com (ALLK)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Allakos Inc.|ALLK - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Allakos|ALLK - Company Aggregate Debts|Debts to Book Capitalization ALLK|ALLK - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Allakos|Interim Coverage Ratio allakos.com
- net income and valuation multiples indicators:
Fundamental valuation:Allakos Inc.
To identify fundamentally resilient companies, an investor analyzes the aggregate of resources and liabilities, reverse-engineered via ROA to eliminate the time lag of quarterly reporting, which allows for an assessment of the business's actual financial stability. In the case of Allakos Inc. (ALLK), this metric reflects the capitalization of the scientific base and the costs of clinical trials for innovative antibodies; therefore, the company's current asset level serves as an indicator of the brand's ability to sustain costly development.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|RIGL - Company Total Assets|AnaptysBio, Inc. (ANAB) - Aggregate Company Assets|ATXS (astriatx.com) - Aggregate Company Assets|Aggregate Company Assets enGene|Aggregate Company Assets RAPT|Company Total Assets JBIO|Company Total Assets Aclaris Therapeutics, Inc (ACRS)|Aggregate Company Assets Kyverna Therapeutics KYTX|Company Total Assets tizianalifesciences.com TLSA|CABA - Aggregate Company Assets|Company Assets Ventyx Biosciences Inc.|Theratechnologies Inc (THTX) - Aggregate Company Assets|AVTX - Company Total Asset Base|Cumulative Company Assets ELDN|AGEN: Aggregate Asset Value|Company Total Assets CLYM|Company Total Asset Base Zura Bio Ltd|Aggregate Company Assets aTyr ATYR|ADAG: Total Business Assets|Ikena Oncology, Inc. - Company Total Assets|Shattuck Labs, Inc. (STTK) - Cumulative Company Assets|EQ (equilliumbio.com) - Cumulative Company Assets|CNTB - Company Total Asset Base|IMUX (Immunic Therapeutics) - Company Total Assets|Company Total Assets Atara Biotherapeutics Inc|Aggregate Company Assets InflaRx N.V. (IFRX)|Aggregate Company Assets XFOR (x4pharma.com)|Aggregate Company Assets Adicet Bio, Inc. ACET|Celularity Inc - Aggregate Company Assets|INMB - Aggregate Company Assets|BRNS - Company Total Assets|Kezar Life Sciences (KZR) - Aggregate Company Assets|Total Asset Value of Company SABS (sabbiotherapeutics.com)|AKTX (Akari Therapeutics Plc) - Company Total Assets|ENLV: Aggregate Asset Value|Company Total Assets QTTB|Company Total Assets GeoVax Corp (GOVX)|Aggregate Company Assets Edesa Biotech, Inc. EDSA|Aggregate Asset Value IBIO|CARM - Aggregate Company Assets|XTL Biopharmaceuticals Ltd (XTLB) - Cumulative Company Assets|BOLT: Company Total Assets|HCW Biologics (HCWB) - Company Total Assets|Cumulative Company Assets APVO|AIM: Aggregate Asset Value|Company Total Assets ADTX|Company Total Asset Base GRI Bio Inc|Aggregate Company Assets XORTX XRTX|HIND - Cumulative Company Assets|REVB - Aggregate Company Assets|indaptusrx.com (INDP) - Cumulative Company Assets|SCNI (Scinai Immunotherapeutics Ltd.) - Cumulative Company Assets|CalciMedica (CALI) - Company Total Assets|Aggregate Company Assets Affimed NV|Total Business Assets HOOK (HOOKIPA)|Company Total Assets IGMS|ITOS - Company Assets|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD - Aggregate Company Assets